CSTL CASTLE BIOSCIENCES INC
Price Chart
Executive Summary
Castle Biosciences insiders executed a cluster of transactions over the past week, primarily involving derivative exercises, share grants, and tax-related share withholdings. The only open-market sales were $135K by a director and $144.8K by the CFO, both relatively small in context. Most activity represents non-cash, routine equity events tied to compensation.
Key Financial Metrics
Actionable Insight
No material insider selling pressure detected — open-market sales are small (<0.1% of $806M market cap) and likely routine. Monitor for continued open-market selling in future filings; current activity aligns with normal equity compensation management.
Key Facts
- Director Cole G Bradley sold 4,748 shares for $135,033 in an open-market transaction.
- CFO Frank Stokes sold 5,300 shares for $144,796 in an open-market transaction.
- CEO, COO, CCO, and CFO exercised stock options and received new share grants (non-cash events).
- CEO Maetzkold surrendered 19,043 shares ($525K value) to cover tax obligations on a grant.
- All other transactions (grants, exercises, tax withholdings) are non-cash and routine for executive compensation.
Financial Impact
$279.8K in total open-market selling; $692K in tax-related share surrenders; $0 in net cash impact from grants/exercises.
Risk Factors
- Perception of insider selling if context is misunderstood (e.g., conflating tax withholding with profit-taking).
- Potential for increased share dilution over time from repeated share grants.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (20 trades, 7d window) | cluster-CSTL-1773087200506 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
8d ago
|
144
| $19.71 $20.39 | ▲ +3.45% | ▲ +4.17% | $20.12 (+2.08%) |
|
May 7, 2026
4w ago
|
144
| $19.83 $19.04 | ▼ −3.98% | ▼ −4.22% | $20.12 (+1.46%) |
|
Apr 8, 2026
8w ago
|
DEFA14A
| $25.19 $23.43 | ▼ −6.99% | ▼ −7.56% | $20.12 (−20.13%) |
|
Mar 13, 2026
12w ago
|
Press Release
| $25.56 $25.83 | ▲ +1.06% | ▲ +0.03% | $20.12 (−21.28%) |
|
Mar 12, 2026
12w ago
|
Insider Cluster
| $25.32 $25.56 | ▼ −0.95% | ▼ −1.55% | $20.12 (+20.54%) |
|
Mar 12, 2026
12w ago
|
Insider Cluster
| $25.32 $25.56 | ▼ −0.95% | ▼ −1.55% | $20.12 (+20.54%) |
|
Mar 9, 2026
13w ago
|
Press Release
| $27.02 $26.60 | ▼ −1.55% | ▼ −1.37% | $20.12 (−25.54%) |
|
Mar 5, 2026
13w ago
|
Insider Cluster
| $27.91 $27.12 | ▲ +2.83% | ▲ +1.52% | $20.12 (+27.91%) |
|
Mar 5, 2026
13w ago
|
Insider Cluster
| $27.91 $27.12 | ▲ +2.83% | ▲ +1.52% | $20.12 (+27.91%) |
|
Mar 3, 2026
14w ago
|
Insider Cluster
| $27.57 $28.17 | ▲ +2.18% | ▲ +1.41% | $20.12 (−27.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access